23 research outputs found

    Discovery and characterization of two new stem rust resistance genes in Aegilops sharonensis

    Get PDF
    Stem rust is one of the most important diseases of wheat in the world. When single stem rust resistance (Sr) genes are deployed in wheat, they are often rapidly overcome by the pathogen. To this end, we initiated a search for novel sources of resistance in diverse wheat relatives and identified the wild goat grass species Aegilops sharonesis (Sharon goatgrass) as a substantial reservoir of resistance to wheat stem rust. The objectives of this study were to discover and map novel Sr genes in Ae. sharonensis and to explore the possibility of identifying new Sr genes by genome-wide association study (GWAS). We developed two biparental populations between resistant and susceptible accessions of Ae. sharonensis and performed QTL and linkage analysis. In an F6 recombinant inbred line and an F2 population, two genes were identified that mapped to the short arm of chromosome 1Ssh, designated as Sr-1644-1Sh, and the long arm of chromosome 5Ssh, designated as Sr-1644-5Sh. The gene Sr-1644-1Sh confers a high level of resistance to race TTKSK (one of the Ug99 lineage races), while the gene Sr-1644-5Sh conditions strong resistance to TRTTF, another widely virulent race found in Yemen. Additionally, GWAS was conducted on 125 diverse Ae. sharonensis accessions for stem rust resistance. The gene Sr-1644-1Sh was detected by GWAS, while Sr-1644-5Sh was not detected, indicating that the effectiveness of GWAS might be affected by marker density, population structure, low allele frequency and other factors

    Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

    Get PDF
    OBJECTIVE: To evaluate whether eculizumab helps patients with anti-acetylcholine receptor-positive (AChR+) refractory generalized myasthenia gravis (gMG) achieve the Myasthenia Gravis Foundation of America (MGFA) post-intervention status of minimal manifestations (MM), we assessed patients' status throughout REGAIN (Safety and Efficacy of Eculizumab in AChR+ Refractory Generalized Myasthenia Gravis) and its open-label extension. METHODS: Patients who completed the REGAIN randomized controlled trial and continued into the open-label extension were included in this tertiary endpoint analysis. Patients were assessed for the MGFA post-intervention status of improved, unchanged, worse, MM, and pharmacologic remission at defined time points during REGAIN and through week 130 of the open-label study. RESULTS: A total of 117 patients completed REGAIN and continued into the open-label study (eculizumab/eculizumab: 56; placebo/eculizumab: 61). At week 26 of REGAIN, more eculizumab-treated patients than placebo-treated patients achieved a status of improved (60.7% vs 41.7%) or MM (25.0% vs 13.3%; common OR: 2.3; 95% CI: 1.1-4.5). After 130 weeks of eculizumab treatment, 88.0% of patients achieved improved status and 57.3% of patients achieved MM status. The safety profile of eculizumab was consistent with its known profile and no new safety signals were detected. CONCLUSION: Eculizumab led to rapid and sustained achievement of MM in patients with AChR+ refractory gMG. These findings support the use of eculizumab in this previously difficult-to-treat patient population. CLINICALTRIALSGOV IDENTIFIER: REGAIN, NCT01997229; REGAIN open-label extension, NCT02301624. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that, after 26 weeks of eculizumab treatment, 25.0% of adults with AChR+ refractory gMG achieved MM, compared with 13.3% who received placebo

    Stability and confinement of nonrelativistic sheet electron beams with periodic cusped magnetic focusing

    No full text
    This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All persons copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder

    Title: Target Characterization in 3D Using Infrared Lidar Target Characterization in 3D Using Infrared Lidar

    No full text
    ABSTRACT We report examples of the use of a scanning tunable CO 2 laser lidar system in the 9-11 µm region to construct images of vegetation and rocks at ranges of up to 5 km from the instrument. Range information is combined with horizontal and vertical distances to yield an image with three spatial dimensions simultaneous with the classification of target type. Object classification is made possible by the distinct spectral signatures of both natural and man-made objects. Several multivariate statistical methods are used to illustrate the degree of discrimination possible among the natural variability of objects in both spectral shape and amplitude

    Analysis of rectangular waveguide-gratings for amplifier applications

    No full text
    This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All persons copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder

    Combination treatment in metastatic prostate cancer: is the bar too high or have we fallen short?

    No full text
    Androgen deprivation therapy (ADT) alone has been the cornerstone of treatment for patients with newly diagnosed metastatic prostate cancer for the past century. Based on results from landmark trials in the past decade, combination approaches of ADT with chemotherapy or novel hormonal agents have established a new standard of care for these patients. This paradigm shift in treatment has been reflected in the updates to guideline recommendations of major professional associations. However, real-world data from around the world have highlighted the dismal adoption of combination therapy, despite evidence-based recommendations. The disparity between evidence and practice is concerning, especially with emerging evidence of survival benefit with further treatment intensification using triplet combinations (ADT, docetaxel and novel hormonal agents). Thus, a pressing need to raise awareness and call the uro-oncology community to action exists to deliver evidence-based care for these patients

    Huygens-Fresnel wave-optics simulation of atmospheric optical turbulence and reflective speckle in CO2 differential absorption LIDAR (DIAL)

    Get PDF
    The measurement sensitivity of C02 differential absorption lidar (DIAL) can be affected by a number of different processes. We have previously developed a Huygens-Fresnel wave optics propagation code to simulate the effects of two of these processes: effects caused by beam propagation through atmospheric optical turbulence and effects caused by reflective speckle. Atmospheric optical turbulence affects the beam distribution of energy and phase on target. These effects include beam spreading, beam wander and scintillation which can result in increased shot-to-shot signal noise. In addition, reflective speckle alone has been shown to have a major impact on the sensitivity of C02 DIAL. However, in real DIAL systems it is a combination of these phenomena, the interaction of atmospheric optical turbulence and reflective speckle, that influences the results. In this work, we briefly review a description of our model including the limitations along with previous simulations of individual effects. The performance of our modified code with respect to experimental measurements affected by atmospheric optical turbulence and reflective speckle is examined. The results of computer simulations are directly compared with lidar measurements and show good agreement. In addition, advanced studies have been performed to demonstrate the utility of our model in assessing the effects for different lidar geometries on RMS noise and correlation "size" in the receiver plane.U.S. Department of EnergyW-7405-ENG-3
    corecore